Indian stock exchange

F3 Announces Revised Bought Deal Private Placement for Gross Proceeds of C$9.0 Million

Retrieved on: 
Thursday, May 2, 2024

Red Cloud Securities Inc. is acting as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the "Underwriters").

Key Points: 
  • Red Cloud Securities Inc. is acting as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the "Underwriters").
  • If the Over-Allotment Option is exercised in full, the total gross proceeds of the Offering will be C$10,000,000.
  • The Company will pay to the Underwriters a cash commission of 5.5% of the gross proceeds raised in respect of the Offering (the "Underwriters' Commission").
  • The proceeds of the Offering will be used by the Company to fund exploration of the Company's projects in the Athabasca Basin.

Archer Exploration Announces Non-Brokered Private Placement, Share Consolidation and Name Change

Retrieved on: 
Friday, April 26, 2024

Subject to approval by the Canadian Securities Exchange (the "CSE"), the Consolidation is expected to be effective May 1, 2024 (the "Effective Day").

Key Points: 
  • Subject to approval by the Canadian Securities Exchange (the "CSE"), the Consolidation is expected to be effective May 1, 2024 (the "Effective Day").
  • Each Unit shall be comprised of one Common Share (a "Unit Share") and one Common Share purchase warrant of the Company (each, a "Warrant").
  • In connection with the Consolidation, the Company has effected the Name Change to "NorthX Nickel Corp.".
  • Letters of transmittal with respect to the Name Change and Consolidation will be mailed out to the Company's registered shareholders after the Effective Day.

Teako Minerals Announces Upsize of its Previously Announced Non-Brokered Private Placement to $900,000 and Closing of First Tranche

Retrieved on: 
Thursday, April 11, 2024

The Company closed the first tranche of the Offering for aggregate gross proceeds of approximately $579,600 (the "First Tranche").

Key Points: 
  • The Company closed the first tranche of the Offering for aggregate gross proceeds of approximately $579,600 (the "First Tranche").
  • The First Tranche of the Offering was subscribed by a group of supportive Danish investors as well as a previous private placement participant from Norway.
  • Under the First Tranche of the Offering, the Company issued 6,439,996 common shares (the "Common Shares") at a price of $0.09 per Common Share.
  • All of the Common Shares issued under the Offering will be subject to a four-month and one-day statutory hold period.

FLINT Announces First Quarter 2024 Financial Results

Retrieved on: 
Thursday, May 2, 2024

Gross profit margin for three months ended March 31, 2024 was 8.9%, which was consistent with the same period in 2023.

Key Points: 
  • Gross profit margin for three months ended March 31, 2024 was 8.9%, which was consistent with the same period in 2023.
  • For the three months ended March 31, 2024, Adjusted EBITDAS was $3,188 compared to $5,444 for the same period in 2023.
  • As a percentage of revenue, Adjusted EBITDAS was 2.2% for the three months ended March 31, 2024 compared to 3.6% for the same period in 2023.
  • Our unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024 and the related Management's Discussion and Analysis of the operating and financial results can be accessed on our website at www.flintcorp.com and will be available shortly through SEDAR+ at www.sedarplus.ca .

Guanajuato Silver Announces Brokered LIFE Offering of Units

Retrieved on: 
Thursday, April 25, 2024

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Guanajuato Silver Company Ltd. (the “Company” or “GSilver”) (TSXV:GSVR) (OTCQX:GSVRF) announces a brokered, best-efforts Listed Issuer Financing Exemption private placement (the “Offering”) consisting of units of the Company (the “Units”) at a price of C$0.20 per Unit (the “Offering Price”) for minimum aggregate gross proceeds of C$6,000,000 and a maximum of up to C$8,625,000. The Offering is being led by Research Capital Corporation and Red Cloud Securities Inc. as the co-lead agents and joint bookrunners, on behalf of a syndicate of agents (collectively, the “Agents”).

Key Points: 
  • Each Warrant will entitle the holder to purchase an additional Common Share at an exercise price of C$0.30 for a period of 24 months following the closing of the Offering.
  • Net proceeds from the Offering will be used to, inter alia:
    add to the Company’s underground fleet and ramp up production at GSilver’s producing mines in Guanajuato and Durango.
  • The Units offered under the Listed Issuer Financing Exemption will be immediately “free-trading” under applicable Canadian securities laws.
  • There is an offering document (the "Offering Document") related to this Offering that can be accessed under the Company's profile at www.sedarplus.ca and at the Company's website at www.gsilver.com .

Longeveron to Present at the Planet MicroCap Showcase

Retrieved on: 
Thursday, April 25, 2024

MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024.

Key Points: 
  • An archived replay of the webcast will be available on the “ Events & Presentations ” section of the Company’s website following the conference.
  • If you would like to book 1x1 investor meetings with Longeveron Inc. and to attend the Planet MicroCap Showcase: VEGAS 2024, please register here: https://planetmicrocapshowcase.com/signup .
  • 1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV.

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Retrieved on: 
Thursday, April 25, 2024

SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.

Key Points: 
  • SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.
  • The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV.
  • The presentation will take place on Wednesday, May 1, 2024 at 9:00 a.m. PT and Mr. Maraoui will be available for one-on-one meetings throughout the conference.
  • Investors can attend the conference and request a meeting with Mr. Maraoui by registering at the link below:

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Retrieved on: 
Thursday, April 25, 2024

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST.

Key Points: 
  • Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST.
  • Ted Karkus, CEO, will be hosting the presentation and answering questions at the conclusion.
  • To access the live presentation, please use the following information:
    If you would like to book 1x1 investor meetings with ProPhase Labs, and to attend the Planet MicroCap Showcase: VEGAS 2024, please make sure you are registered here: https://planetmicrocapshowcase.com/signup
    1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV
    The Planet MicroCap Showcase: VEGAS 2024 website is available here: https://planetmicrocapshowcase.com/
    If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: https://planetmicrocapshowcase.com/agenda

Royal Helium Announces $6 Million Bought Deal Public Offering of Units for Drilling of High-Impact Appraisal Well at 40 Mile and Continued Advancement in Saskatchewan Helium Corridor

Retrieved on: 
Thursday, April 25, 2024

SASKATOON, Saskatchewan, April 24, 2024 (GLOBE NEWSWIRE) -- Royal Helium Ltd. (TSXV:RHC) (OTCQB:RHCCF) ("Royal" or the "Company") is pleased to announce that it has entered into an agreement with Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters has agreed to purchase, on a bought deal basis, 66,667,000 units of the Company (the “Units”) at a price of $0.09 per Unit for aggregate gross proceeds to the Company of $6,000,030 (the "Offering").

Key Points: 
  • The Shelf Prospectus and the Prospectus Supplement will contain, important detailed information about the Company and the Offering.
  • Given the increasing demand for purified helium, Royal Helium anticipates a robust pricing environment for the foreseeable future.
  • Royal completed seismic work at 40 Mile in 2023 and has multiple seismically defined drill targets across multiple prospective zones.
  • The Val Marie helium project comprises a 32,000-acre, 21-year lease land package representing approximately 3% of Royal's current helium permit and lease lands across Saskatchewan and Alberta.

MARKSMEN ANNOUNCES TERMINATION OF PREVIOULSY ANNOUNCED PRIVATE PLACEMENT, PROPOSED NEW PRIVATE PLACEMENT AND RESIGNATION OF DIRECTOR AND OFFICER

Retrieved on: 
Wednesday, April 24, 2024

The Units will be comprised of one (1) common share (“Common Share”) and one (1) share purchase warrant (“Warrant”) of Marksmen.

Key Points: 
  • The Units will be comprised of one (1) common share (“Common Share”) and one (1) share purchase warrant (“Warrant”) of Marksmen.
  • Each whole Warrant entitles the holder thereof to purchase one Common Share for $0.05 expiring two (2) years from the date of the closing of the Offering.
  • The Offering is being offered to all of the existing shareholders of Marksmen who are permitted to subscribe pursuant to the Existing Security Holder Exemption.
  • The Company also announces the resignation of Martin Shumway, as a director and officer of Marksmen, and its subsidiary, Marksmen Energy USA, Inc. Marksmen thanks Mr. Shumway for his contributions to the Company and wishes him success in his future endeavors.